Searchable abstracts of presentations at key conferences in endocrinology

ea0016p269 | Endocrine disruptors | ECE2008

The UV absorber 4-methylbenzylidene-camphor (4-MBC) causes effects comparable to primary hypothyroidism

Gotthardt Inka , Schmutzler Cornelia , Petra Kirschmeyer , Wolfgang Wuttke , Hubertus Jarry , Josef Kohrle

The endocrine active compound 4-methylbenzylidene-camphor (4-MBC) is frequently used as an UV absorber in sunscreens and various skin care products. Though 4-MBC is weakly estrogenic in the reproductive system of fishes and rodents it shows strong anti-osteoporotic effects. Furthermore, different studies show percutanous absorption of 4-MBC after dermal administration resulting in identical biotransformation in humans and rats. Female Sprague-Dawley rats received five concentr...

ea0016p290 | Endocrine tumours | ECE2008

Down-regulation of ENO1/MBP-1 gene products by retinoic acid (RA) causes decreased proliferation of the follicular thyroid carcinoma cell line FTC-133

Trojanowicz Bogusz , Winkler Anja , Hammje Kathrin , Chen Zhouxun , Sekulla Carsten , Glanz Dagobert , Schmutzler Cornelia , Mentrup Birgit , Hombach-Klonisch Sabine , Klonisch Thomas , Finke Rainer , Kohrle Josef , Dralle Henning , Hoang-Vu Cuong

Retinoic acid (RA) acts as an anti-proliferative and re-differentiation agent in the therapy of thyroid carcinoma but the molecular mechanisms by which RA mediates these effects are not well understood. We have investigated the effect of RA on the production and post-translational modification of the two ENO1 transcriptional products in the human follicular thyroid carcinoma cell line FTC-133. The single ENO1 transcript encodes a 48 kDa ENO1 with its unique N-terminal enolase ...